{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T11:16:29Z","timestamp":1762686989065,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271505"],"award-info":[{"award-number":["82271505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Medical University Student Innovation Ability Promoting Program","award":["2022A045"],"award-info":[{"award-number":["2022A045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Epileptologica"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The <jats:italic>TSC1<\/jats:italic> gene encodes a growth inhibitory protein hamartin, which plays a crucial role in negative regulation of the activity of mTORC1 (mechanistic target of rapamycin complex 1). <jats:italic>TSC1<\/jats:italic> has been associated with tuberous sclerosis complex (TSC). This study aims to investigate the association between <jats:italic>TSC1<\/jats:italic> variants and common epilepsy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Trio-based whole-exome sequencing was performed in epilepsy patients without acquired etiologies from the China Epilepsy Gene 1.0 Project platform. The pathogenicity of the variants was evaluated according to the American College of Medical Genetics and Genomic (ACMG) guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two <jats:italic>TSC1 de novo<\/jats:italic> variants, including c.1498\u00a0C\u2009&gt;\u2009T\/p.Arg500* and c.2356\u00a0C\u2009&gt;\u2009T\/p.Arg786*, were identified in two patients with developmental and epileptic encephalopathy (DEE). The patients exhibited frequent seizures and neurodevelopmental delay. Additionally, we identified two heterozygous <jats:italic>TSC1<\/jats:italic> variants that affected four individuals with focal epilepsy from two unrelated families. The four probands did not present any typical symptom of TSC and had normal brain MRI findings. The four variants were absent in the Genome Aggregation Database (gnomAD) and were predicted to be damaging with a in silico prediction tool. Based on the ACMG guidelines, the four variants were evaluated to be \u201cpathogenic\u201d or \u201clikely pathogenic\u201d. Of the patients in the China Epilepsy Gene 1.0 Project, 22 patients carried <jats:italic>TSC1<\/jats:italic> variants and were diagnosed with TSC. The ratio of patients carrying <jats:italic>TSC1<\/jats:italic> variants with or without TSC is about 5:1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p><jats:italic>TSC1<\/jats:italic> is potentially associated with common epilepsy without tuberous sclerosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42494-024-00189-w","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:01:31Z","timestamp":1732838491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Variants of TSC1 are associated with developmental and epileptic encephalopathy and focal epilepsy without tuberous sclerosis"],"prefix":"10.1186","volume":"6","author":[{"given":"Nanxiang","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9929-9185","authenticated-orcid":false,"given":"Weiping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"issue":"7518","key":"189_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nature13492","volume":"513","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Nicholatos J, Dreier JR, Ricoult SJH, Widenmaier SB, Hotamisligil GS, et al. Coordinated regulation of protein synthesis and degradation by mTORC1. Nature. 2014;513(7518):440\u20133.","journal-title":"Nature"},{"issue":"21","key":"189_CR2","doi-asserted-by":"publisher","first-page":"13571","DOI":"10.1073\/pnas.202476899","volume":"99","author":"AR Tee","year":"2002","unstructured":"Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. Tuberous sclerosis complex-1 and \u2013\u20092 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA. 2002;99(21):13571\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"189_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","volume":"11","author":"DJ Kwiatkowski","year":"2002","unstructured":"Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, El-Hashemite N, et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet. 2002;11(5):525\u201334.","journal-title":"Hum Mol Genet"},{"issue":"13","key":"189_CR4","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/hmg\/ddi190","volume":"14","author":"C Wilson","year":"2005","unstructured":"Wilson C, Idziaszczyk S, Parry L, Guy C, Griffiths DFR, Lazda E, et al. A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma. Hum Mol Genet. 2005;14(13):1839\u201350.","journal-title":"Hum Mol Genet"},{"issue":"6 Suppl 3","key":"189_CR5","first-page":"S2","volume":"62","author":"A Palmini","year":"2004","unstructured":"Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, et al. Terminology and classification of the cortical dysplasias. Neurology. 2004;62(6 Suppl 3):S2\u20138.","journal-title":"Neurology"},{"issue":"9639","key":"189_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"372","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372(9639):657\u201368.","journal-title":"Lancet"},{"issue":"1","key":"189_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10038-002-8651-8","volume":"47","author":"T Sato","year":"2002","unstructured":"Sato T, Seyama K, Fujii H, Maruyama H, Setoguchi Y, Iwakami S-i, et al. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet. 2002;47(1):20\u20138.","journal-title":"J Hum Genet"},{"issue":"13","key":"189_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355(13):1345\u201356.","journal-title":"N Engl J Med"},{"issue":"4","key":"189_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nm.3824","volume":"21","author":"JS Lim","year":"2015","unstructured":"Lim JS, Kim W-i, Kang H-C, Kim SH, Park AH, Park EK, et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med. 2015;21(4):395\u2013400.","journal-title":"Nat Med"},{"key":"189_CR10","doi-asserted-by":"crossref","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22(4):489\u2013501.","DOI":"10.1111\/j.1528-1157.1981.tb06159.x"},{"issue":"4","key":"189_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","volume":"51","author":"AT Berg","year":"2010","unstructured":"Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on classification and terminology, 2005\u20132009. Epilepsia. 2010;51(4):676\u201385.","journal-title":"Epilepsia"},{"issue":"4","key":"189_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and terminology. Epilepsia. 2017;58(4):512\u201321.","journal-title":"Epilepsia"},{"issue":"10","key":"189_CR13","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1093\/brain\/awab164","volume":"144","author":"J Wang","year":"2021","unstructured":"Wang J, Qiao J-D, Liu X-R, Liu D-T, Chen Y-H, Wu Y, et al. UNC13B variants associated with partial epilepsy with favourable outcome. Brain. 2021;144(10):3050\u201360.","journal-title":"Brain"},{"key":"189_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.seizure.2023.09.021","volume":"116","author":"MW Zhang","year":"2024","unstructured":"Zhang MW, Liang XY, Wang J, Gao LD, Liao HJ, He YH, et al. Epilepsy-associated genes: an update. Seizure. 2024;116:4\u201313.","journal-title":"Seizure"},{"issue":"5","key":"189_CR15","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/ijms21051642","volume":"21","author":"F Limanaqi","year":"2020","unstructured":"Limanaqi F, Biagioni F, Busceti CL, Fabrizi C, Frati A, Fornai F. mTOR-related cell-clearing systems in epileptic seizures, an update. Int J Mol Sci. 2020;21(5):1642.","journal-title":"Int J Mol Sci"},{"key":"189_CR16","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1038\/s41467-021-26131-z","volume":"12","author":"M Pagani","year":"2021","unstructured":"Pagani M, Barsotti N, Bertero A, Trakoshis S, Ulysse L, Locarno A, et al. mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity. Nat Commun. 2021;12(1):6084.","journal-title":"Nat Commun"},{"issue":"9","key":"189_CR17","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3390\/genes12091401","volume":"12","author":"E Kovesdi","year":"2021","unstructured":"Kovesdi E, Ripszam R, Postyeni E, Horvath EB, Kelemen A, Fabos B, et al. Whole exome sequencing in a series of patients with a clinical diagnosis of tuberous sclerosis not confirmed by targeted TSC1\/TSC2 sequencing. Genes. 2021;12(9):1401.","journal-title":"Genes"},{"issue":"5","key":"189_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s10038-018-0416-0","volume":"63","author":"EN Suspitsin","year":"2018","unstructured":"Suspitsin EN, Yanus GA, Dorofeeva MY, Ledashcheva TA, Nikitina NV, Buyanova GV, et al. Pattern of TSC1 and TSC2 germline mutations in Russian patients with tuberous sclerosis. J Hum Genet. 2018;63(5):597\u2013604.","journal-title":"J Hum Genet"},{"key":"189_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101974","volume":"200","author":"CL LaSarge","year":"2021","unstructured":"LaSarge CL, Pun RYK, Gu Z, Riccetti MR, Namboodiri DV, Tiwari D, et al. mTOR-driven neural circuit changes initiate an epileptogenic cascade. Prog Neurobiol. 2021;200: 101974.","journal-title":"Prog Neurobiol"},{"issue":"3","key":"189_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5607\/en.2015.24.3.177","volume":"24","author":"DY Lee","year":"2015","unstructured":"Lee DY. Roles of mTOR Signaling in Brain Development. Exp Neurobiol. 2015;24(3):177\u201385.","journal-title":"Exp Neurobiol"},{"key":"189_CR21","doi-asserted-by":"crossref","unstructured":"Leo A, Constanti A, Coppola A, Citraro R, Sarro GD, Russo E. mTOR Signaling in Epilepsy and Epileptogenesis: Preclinical and Clinical Studies. In: Molecules to Medicine with mTOR. Maiese K, editor(s). Molecules to Medicine with mTOR. London: Academic Press; 2006. p. 123\u2013142.","DOI":"10.1016\/B978-0-12-802733-2.00006-2"},{"issue":"5","key":"189_CR22","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1086\/302381","volume":"64","author":"AC Jones","year":"1999","unstructured":"Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, Tomkins S, et al. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet. 1999;64(5):1305\u201315.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"189_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68(1):64\u201380.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"189_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/jhg.2013.3","volume":"58","author":"Y Niida","year":"2013","unstructured":"Niida Y, Wakisaka A, Tsuji T, Yamada H, Kuroda M, Mitani Y, et al. Mutational analysis of TSC1 and TSC2 in Japanese patients with tuberous sclerosis complex revealed higher incidence of TSC1 patients than previously reported. J Hum Genet. 2013;58(4):216\u201325.","journal-title":"J Hum Genet"},{"issue":"1","key":"189_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s11689-019-9289-6","volume":"11","author":"M Wong","year":"2019","unstructured":"Wong M. The role of glia in epilepsy, intellectual disability, and other neurodevelopmental disorders in tuberous sclerosis complex. J Neurodev Disord. 2019;11(1):30.","journal-title":"J Neurodev Disord"},{"issue":"10056","key":"189_CR26","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA French","year":"2016","unstructured":"French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388(10056):2153\u201363.","journal-title":"Lancet"},{"issue":"5","key":"189_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.23960","volume":"74","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol. 2013;74(5):679\u201387.","journal-title":"Ann Neurol"}],"container-title":["Acta Epileptologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-024-00189-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42494-024-00189-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-024-00189-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T01:03:13Z","timestamp":1732842193000},"score":1,"resource":{"primary":{"URL":"https:\/\/aepi.biomedcentral.com\/articles\/10.1186\/s42494-024-00189-w"}},"subtitle":["For the China Epilepsy Gene 1.0 Project"],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["189"],"URL":"https:\/\/doi.org\/10.1186\/s42494-024-00189-w","relation":{},"ISSN":["2096-9384","2524-4434"],"issn-type":[{"type":"print","value":"2096-9384"},{"type":"electronic","value":"2524-4434"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed according to the ethical standards of the institutional committee. This study was approved by the Ethics Committee of the Second Affiliated Hospital of Guangzhou Medical University (approval ethics number 2020-hs-49). This study was conducted with written informed consent obtained from the individuals or the legal guardians of the children participating in the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author Weiping Liao is the member of the Editorial Board of <i>Acta Epileptologica<\/i>, who was not involved in the journal\u2019s review of or decisions related to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}